|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $20,805 and $53,696 at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease – right-of-use asset | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Digital assets | ||||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Accrued preferred stock redemption payable (H-7) | ||||||||||||||||||||
| Series H-7 Convertible Preferred Stock | ||||||||||||||||||||
| Total accrued preferred stock redemption payable (H-7) | ||||||||||||||||||||
| Current portion lease obligation – operating lease | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Anti-dilution liability | ||||||||||||||||||||
| Lease obligation - operating lease, net of current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable preferred stock, value | ||||||||||||||||||||
| Series H-7 Convertible Preferred Stock | ||||||||||||||||||||
| Series I Convertible Preferred Stock | ||||||||||||||||||||
| Series K Convertible Preferred Stock | ||||||||||||||||||||
| Series J Convertible Preferred Stock | ||||||||||||||||||||
| Total redeemable preferred stock, value | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common Stock, ($0.0001 par value; authorized – 1,200,000,000 and 200,000,000 shares as of June 30, 2026, and December 31, 2025, respectively; issued and outstanding – 6,663,912 and 1,455,975 shares as of June 30, 2026, and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ equity |
Loading...
